Company / R&D per Share
PROCEPT BioRobotics Corp R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.30
FY2025
5-year range
$0.95 / $3.45
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
#64 of 108
Health Care
What the data says
At $1.30, PROCEPT BioRobotics Corp's r&d per share ranks #64 of 108 in the Health Care sector. Improved from $0.95 to $1.30 over the past 2 years.
Based on SEC 10-K filings.
1.30 in FY2025 with a 5-year CAGR of -21.8%.
Improved from $0.95 to $1.30 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- -21.8%
- 10-Year CAGR
- -
Sector benchmark
#64 of 108 in Health CareTop 59% of 108This company $1.30 Sector average $2.07
▼
-37.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 6.2% year-over-year.
- Ranks #64 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.30 | +6.2% |
| FY2024 | $1.23 | +28.6% |
| FY2023 | $0.95 | -17.2% |
| FY2022 | $1.15 | -66.6% |
| FY2021 | $3.45 | -22.3% |
| FY2020 | $4.44 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026